Irbesartan vs Pembrolizumab
Irbesartan vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Irbesartan and Pembrolizumab.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Irbesartan — 11-15 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Irbesartan — C25H28N6O.
Molecular Weight: Irbesartan — 428.5320 g/mol.
Type: Irbesartan — Small molecule; Pembrolizumab — Antibody.